Eugene Bauer

CIK: 0001678620

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EVMN

Evommune, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

EVMN
Evommune, Inc.
Apr 16, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
51.1K shares-
EVMN
Evommune, Inc.
Dec 9, 2025
Tax Payment(F)
Direct
1.5K shares at avg. $17.84$26K
EVMN
Evommune, Inc.
Dec 8, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
100K shares-
EVMN
Evommune, Inc.
Nov 7, 2025
Conversion(C)
Direct
25.8K shares-

		Type	Shares	Price		Ownership
Apr 16, 2026	EVMN Evommune, Inc.	Award(A) Employee Stock Option (Right to Buy)	51,117	-	-	Direct
Dec 9, 2025	EVMN Evommune, Inc.	Tax Payment(F)	1,478	$17.84	$26,368	Direct
Dec 8, 2025	EVMN Evommune, Inc.	Award(A) Employee Stock Option (Right to Buy)	100,000	-	-	Direct
Nov 7, 2025	EVMN Evommune, Inc.	Conversion(C)	25,812	-	-	Direct

1-4 of 4 transactions

About Bauer Eugene

Bauer Eugene (SEC CIK 0001678620) files insider reports with the SEC as Chief Medical Officer of Evommune, Inc. (EVMN).

Signal8 holds 5 ownership filings by Bauer Eugene (1 Form 3, 4 Form 4), filed between Nov 5, 2025 and Apr 17, 2026. Those filings report 4 transactions, from Nov 7, 2025 to Apr 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bauer Eugene's filings is in PALO ALTO, CA.

Recent filings by Bauer Eugene

Apr 16, 2026: Grant or award of EVMN derivative securities (Form 4, code A).
Dec 9, 2025: Tax withholding of EVMN shares (Form 4, code F).
Dec 8, 2025: Grant or award of EVMN derivative securities (Form 4, code A).
Nov 7, 2025: Conversion of EVMN shares (Form 4, code C).

Other insiders filing for Evommune, Inc. (EVMN)

Pena Luis C., President & CEO
Carver Kyle, Chief Financial Officer
KIRSCH ARTHUR S, Director
Drew Janice Suzann, Chief of Dev. Operations
Patel Jeegar Pravinkumar, Chief Scientific Officer
MCGRAW BENJAMIN F III, Director

How to read Form 4 transaction codes